Literature DB >> 11186137

CYP3A4 promoter variant in Saudi, Ghanaian and Scottish Caucasian populations.

M T Tayeb1, C Clark, M M Ameyaw, N E Haites, D A Evans, M Tariq, A Mobarek, D Ofori-Adjei, H L McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186137     DOI： 10.1097/00008571-200011000-00009

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  10 in total

1.  Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance.

Authors:  Alessandro Schipani; Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Marco Simiele; Stefano Bonora; Sonia Rodríguez Novoa; Lorena Cuenca; Vincent Soriano; Nitipatana Chierakul; Natpratou Saguenwong; Charoen Chuchuttaworn; Janelle M Hoskins; Anne M Dvorak; Howard L McLeod; Gerry Davies; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Pharmacogenetics in Ghana: reviewing the evidence.

Authors:  W Kudzi; G O Adjei; D Ofori-Adjei; A N O Dodoo
Journal:  Ghana Med J       Date:  2011-06

Review 3.  Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.

Authors:  Keneuoe Cecilia Nthontho; Andrew Khulekani Ndlovu; Kirthana Sharma; Ishmael Kasvosve; Daniel Louis Hertz; Giacomo Maria Paganotti
Journal:  Pharmgenomics Pers Med       Date:  2022-06-21

4.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

Review 5.  Genetic polymorphisms and prostate cancer risk.

Authors:  Andrea Gsur; Elisabeth Feik; Stephan Madersbacher
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226

6.  Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish Patients with Major Depressive Disorder.

Authors:  Zuhal Uçkun; Bora Baskak; Hatice Özdemir; Erguvan Tuğba Özel-Kizil; Halise Devrimci-Özgüven; Halit Sinan Süzen
Journal:  Turk J Pharm Sci       Date:  2018-07-17

7.  Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

Authors:  William Kudzi; Alexander N O Dodoo; Jeremy J Mills
Journal:  BMC Med Genet       Date:  2010-07-14       Impact factor: 2.103

8.  Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.

Authors:  Karol J Marwa; Theresa Schmidt; Maria Sjögren; Omary M S Minzi; Erasmus Kamugisha; Göte Swedberg
Journal:  Malar J       Date:  2014-11-03       Impact factor: 2.979

9.  Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia.

Authors:  Gamal T Ali; Nevin M Al-Azhary; Doha A Mokhtar
Journal:  J Adv Res       Date:  2013-10-30       Impact factor: 10.479

10.  CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.

Authors:  M T Tayeb; C Clark; N E Haites; L Sharp; G I Murray; H L McLeod
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.